ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nicotinamide Supplementation Attenuates Renal Interstitial Fibrosis via Boosting the Activity of Sirtuins

Zhen, Xin; Zhang, Shaowu; Xie, Feifei; Zhou, Miaomiao; Hu, Zheng; Zhu, Fengxin; Nie, Jing*南方医科大学
Kidney Diseases2021-5DOI: 10.1159/000510943
11被引8阅读
引用收藏
分享

摘要

Background: Progressive tubulointerstitial fibrosis (TIF) is the final common pathway leading to ESRD. There is an urgent need to develop effective approaches slowing the progression of TIF. Previous studies showed that systemic supplementation of nicotinamide (NAM) increases renal NAD(+) and reverses ischemic-reperfusion induced acute renal injury. However, the role and mechanism of NAM in TIF has been unclear. Methods: In vivo, we injected NAM (0.25 mg/g) 3 days before unilateral ureter obstruction (UUO) till day 7 post-operation. In vitro, mouse primary proximal tubular epithelial cells (PTCs), rat renal NRK-49F cells, and human renal proximal tubular epithelial cell (HK-2) were pretreated with the indicated concentration of NAM 1 h before incubation with transform growth factor-beta 1 (TGF-beta 1) or aristolochic acid (AA) for 24 or 48 h. To evaluate the role of sirtuins (SIRTs), PTCs were pretreated with EX527 or resveratrol 30 min before incubation with NAM and TGF-beta 1. Results: In the present study, we demonstrated that NAM supplementation prevented UUO-induced TIF, and AA-induced renal injury. NAM also decreased the expression of pro-fibrotic proteins and pro-inflammatory cytokines (IL-6 and TNF-alpha) and attenuated interstitial inflammation. In vitro experiment showed that, NAM inhibited AA-induced G2/M arrest of HK-2 cells by downregulating the expression of cyclin G1, a target gene of p53. In addition, NAM inhibited TGF-beta 1-induced fibroblast proliferation and activation shown as downregulated expression of collagen I, fibronectin, PCNA, cyclin D1, IL-6, and TNF-alpha. NAM decreased the acetylation of Smad3 and p53. EX527, an inhibitor of SIRT1, reversed the effect of NAM on TGF-beta 1-induced matrix protein production. However, resveratrol, a SIRT1 activator, did not further boost the protective effect of NAM on reducing matrix protein production. Conclusions: Taken together, these data indicate that NAM supplementation could inhibit TIF at least partially by boosting the activity of sirtuins.

学科与关键词

关键词
NicotinamideRenal interstitial fibrosisSirtuinsG2/M arrestInflammation
相关
加载中…
  • Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway
    Zhang, Wenying; Rong, Guang; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Jiang, Tingting; Deng, Weiqian; Xie, Jiayu; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun*; Zhang, Jun*FASEB Journal, 2022, 36(3): e22084.被引 14
  • Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition
    Zhou, Ruimei; Liao, Jiashun; Cai, Dunpeng; Tian, Qin; Huang, Enping; Lu, Tianming; Chen, Shi-You*; Xie, Wei-Bing*FASEB Journal, 2021, 35(3): e21381.被引 11
  • FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial-mesenchymal transition
    Wang, Yanhui; Zhou, Qiaoling*; Tang, Rong; Huang, Yuyu; He, TingJournal of Pharmacological Sciences, 2020, 143(4): 281-289.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Kidney Diseases
发表日期
2021-05
卷期
第 7 卷, 第 3 期
页码
186-199
DOI
10.1159/000510943
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Nature and Science Foundation of China [81730019, 81521003]; President Foundation of Nanfang Hospital, Southern Medical University [2017Z011, 2017Z019]

作者

  • Z

    Zhen, Xin (第一作者)

    southern med univ

  • Z

    Zhang, Shaowu

    southern med univ

查看全部 7 位作者收起作者
  • X

    Xie, Feifei

    southern med univ

  • Z

    Zhou, Miaomiao

    southern med univ

  • H

    Hu, Zheng

    southern med univ

  • Z

    Zhu, Fengxin

    southern med univ

  • N

    Nie, Jing (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417